Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
24051studies shown
Showing 157-168 of 24,051
Drug study icon
RecruitingNCT06569394

Cannabidiol in Young Adult Cannabis Users

The registry lists this study as recruiting. Study locations are listed in the United States.

In Aurora
AddictionDrugA study involving a medication or substance.From 18 Years to 25 Years
Countries
United States
Sponsor
University of Colorado, Denver
Condition
Addiction
Biological study icon
RecruitingNCT03588975

MACI for OCD

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Palo Alto
OCDBiologicalFrom 10 Years to 17 Years
Countries
United States
Sponsor
Vericel Corporation
Condition
OCD
Drug study icon
RecruitingNCT07323784

NTX-1472 in Social Anxiety Disorder

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Encino
AnxietyDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Newleos Therapeutics, Inc.
Condition
Anxiety
Drug study icon
RecruitingNCT07263191

Olanzapine in people with Bipolarity.

The registry lists this study as recruiting. Study locations are listed in South Korea.

In Seongnam
BipolarityDrugOver 19 Years
Countries
South Korea
Sponsor
Boryung Pharmaceutical Co., Ltd
Condition
Bipolarity
Drug study icon
RecruitingNCT06655883

Suvorexant for Addiction

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Garden Grove
AddictionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Merck Sharp & Dohme LLC
Condition
Addiction
Drug study icon
RecruitingNCT07615426

Aticaprant for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Garden Grove
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Janssen Research & Development, LLC
Condition
Schizophrenia
Other study type icon
RecruitingISRCTN58916738

The impact on wellbeing of HS2

The registry lists this study as recruiting. Study locations are listed in the United Kingdom.

In United Kingdom
Mental healthOtherOver 18 Years
Countries
United Kingdom
Sponsor
RAND Europe
Condition
Mental health
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.